Literature DB >> 10410966

Affinity-purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture.

R Fischer1, Y C Liao, J Drossard.   

Abstract

A TMV-specific full-size murine IgG-2b/K antibody (mAb24) was expressed in a Nicotiana tabacum cv. Petite Havana SR1 suspension culture (P9s), which was derived from a stably transformed transgenic plant (P9). The integration of an N-terminal murine leader peptide directed the assembled immunoglobulin for secretion. However, in suspension culture, the full-size recombinant antibody, rAb24, was retained by the plant cell wall and was not present in the culture medium. rAb24 expression reached a basal level of 15 microg per gram wet cell weight, corresponding to 0.3% of the total soluble plant cell protein. The level of rAb24 could be increased three-fold by amino acid supplementation of the culture medium. For purification of the recombinant antibody from batch-cultured tobacco suspension cells, the primary plant cell wall was partially digested by enzymatic treatment. This resulted in a total release of recombinant full-size rAb24 into the extraction buffer. A three-step procedure was used to purify the immunoglobulins, starting with cross-flow filtration (step 1) followed by protein A affinity chromatography (step 2) and gel filtration as a final purification step (step 3). This procedure gave a recovery of more than 80% of the expressed rAb24 from plant cell extracts. SDS-PAGE, IEF and immunoblot analyses demonstrated a high degree of homogeneity for the affinity-purified rAb24. An ELISA procedure demonstrated that the specificity and affinity of the protein A affinity purified antibody was indistinguishable from its murine counterpart, indicating the potential of plant cell suspension cultures as bio-reactors for the production of recombinant antibodies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10410966     DOI: 10.1016/s0022-1759(99)00058-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

Review 1.  'Molecular farming' of antibodies in plants.

Authors:  Stefan Schillberg; Rainer Fischer; Neil Emans
Journal:  Naturwissenschaften       Date:  2003-02-18

2.  Different subcellular localization and glycosylation for a functional antibody expressed in Nicotiana tabacum plants and suspension cells.

Authors:  Benoit De Muynck; Catherine Navarre; Yannick Nizet; Johannes Stadlmann; Marc Boutry
Journal:  Transgenic Res       Date:  2009-01-14       Impact factor: 2.788

3.  High-efficiency Agrobacterium rhizogenes-mediated transformation of heat inducible sHSP18.2-GUS in Nicotiana tabacum.

Authors:  Shih-Cheng Chen; Hui-Wen Liu; Kung-Ta Lee; Takashi Yamakawa
Journal:  Plant Cell Rep       Date:  2006-07-28       Impact factor: 4.570

4.  Purification of the therapeutic antibody trastuzumab from genetically modified plants using safflower Protein A-oleosin oilbody technology.

Authors:  Michael D McLean; Rongji Chen; Deqiang Yu; Kor-Zheng Mah; John Teat; Haifeng Wang; Steve Zaplachinski; Joseph Boothe; J Christopher Hall
Journal:  Transgenic Res       Date:  2012-03-02       Impact factor: 2.788

5.  Optimisation of the purification process of a tumour-targeting antibody produced in N. benthamiana using vacuum-agroinfiltration.

Authors:  Raffaele Lombardi; Maria Elena Villani; Mariasole Di Carli; Patrizia Brunetti; Eugenio Benvenuto; Marcello Donini
Journal:  Transgenic Res       Date:  2010-03-15       Impact factor: 2.788

6.  Simple and portable magnetic immunoassay for rapid detection and sensitive quantification of plant viruses.

Authors:  Stefanie Rettcher; Felicitas Jungk; Christoph Kühn; Hans-Joachim Krause; Greta Nölke; Ulrich Commandeur; Rainer Fischer; Stefan Schillberg; Florian Schröper
Journal:  Appl Environ Microbiol       Date:  2015-02-20       Impact factor: 4.792

Review 7.  Evolution of plant-made pharmaceuticals.

Authors:  David R Thomas; Claire A Penney; Amrita Majumder; Amanda M Walmsley
Journal:  Int J Mol Sci       Date:  2011-05-17       Impact factor: 5.923

Review 8.  Molecular farming of pharmaceutical proteins.

Authors:  R Fischer; N Emans
Journal:  Transgenic Res       Date:  2000       Impact factor: 3.145

Review 9.  Plant-made vaccines for humans and animals.

Authors:  Edward P Rybicki
Journal:  Plant Biotechnol J       Date:  2010-03-11       Impact factor: 9.803

10.  Sucrose density gradient centrifugation and cross-flow filtration methods for the production of arbovirus antigens inactivated by binary ethylenimine.

Authors:  Alyssa T Pyke; Debra A Phillips; Teck F Chuan; Greg A Smith
Journal:  BMC Microbiol       Date:  2004-01-14       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.